Welcome to the official account for BEXSERO.
Community Guidelines: https://gsk.to/42csfAD
Prescribing Information: https://gskp.ro/47Abp0X
Intended for US healthcare professionals only.
Trademarks are owned by or licensed to the GSK group of companies.
©2024 GSK or licensor.
PMUS-BEXSMP240017 August 2024
Produced in USA.
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.bexserohcp.com/
- Keywords
- New York.
Bexsero (Meningococcal Group B Vaccine) Questions
Bexsero (Meningococcal Group B Vaccine)'s website is https://www.bexserohcp.com/
Bexsero (Meningococcal Group B Vaccine)'s LinkedIn profile is https://www.linkedin.com/company/bexserohcp
Bexsero (Meningococcal Group B Vaccine)'s industry is
Pharmaceutical Manufacturing
Bexsero (Meningococcal Group B Vaccine)'s top competitors are
Professional Safety Solutions Llc,
Mrm,
Leqvio® (Inclisiran) Hcp,
Repatha® (Evolocumab) Hcp,
451 Media Group Llc,
Menquadfi® Meningococcal (Groups A,c,y,w) Conjugate Vaccine,
Alecensa® (Alectinib),
Lokelma® (Sodium Zirconium Cyclosilicate) Hcp,
Hillside Health Care,
Optimal Studio.
Bexsero (Meningococcal Group B Vaccine)'s categories are Pharmaceutical Manufacturing
